2013 Annual National Digital Rectal Exam (DRE) Day Study

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

NCT04947631 ·Status: COMPLETED ·Phase: PHASE3

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

NCT02592473 ·Status: UNKNOWN ·Phase: NA

An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

NCT01351987 ·Status: UNKNOWN

Safety and Pharmacokinetic Characteristics of DKF-313

NCT02352311 ·Status: COMPLETED ·Phase: PHASE1

Impact of Mirabegron on Erectile Function in BPH Patients

NCT04503850 ·Status: UNKNOWN

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

NCT00037141 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia

NCT02033798 ·Status: UNKNOWN ·Phase: NA

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia

NCT06520267 ·Status: COMPLETED

A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia

NCT01387893 ·Status: COMPLETED ·Phase: NA

Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer

NCT00773305 ·Status: COMPLETED

A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

NCT01003886 ·Status: COMPLETED

Benign Prostatic Hyperplasia and Glycosaminoglycan

NCT03955484 ·Status: UNKNOWN

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

NCT05530655 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

NCT06051383 ·Status: COMPLETED ·Phase: NA

UK ROPE Register Study

NCT02434575 ·Status: COMPLETED

A Study to Evaluate the Effects of a Prostate Health Formulation

NCT02886832 ·Status: COMPLETED ·Phase: NA

Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

NCT02930889 ·Status: COMPLETED ·Phase: NA

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

NCT01678313 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

NCT05558007 ·Status: RECRUITING ·Phase: PHASE2

PSA Glycomics Assay for Early Detection of Prostate Cancer

NCT04393376 ·Status: UNKNOWN ·Phase: NA

Prostatic Artery Embolization for Benign Prostatic Hyperplasia

NCT01835860 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH

NCT04245566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Impact of TURP on Quality of Life in Patients With Benign Prostatic Hyperplasia: A Retrospective Study

NCT06995963 ·Status: COMPLETED

Identification and Treatment of Men With BPH in the Primary Care Setting

NCT00211640 ·Status: COMPLETED

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

NCT02873117 ·Status: COMPLETED